首页 | 本学科首页   官方微博 | 高级检索  
检索        

奥施康定和芬太尼透皮贴治疗中一重度癌痛的临床观察
引用本文:秦鑫添,李玉齐,王希成,舒阳春,刘魁凤.奥施康定和芬太尼透皮贴治疗中一重度癌痛的临床观察[J].医疗保健器具,2011(2):229-231.
作者姓名:秦鑫添  李玉齐  王希成  舒阳春  刘魁凤
作者单位:广东药学院附属第一医院肿瘤科;
摘    要:目的对比观察奥施康定(盐酸羟考嗣控释片)和芬太尼透皮贴治疗慢性中、重度癌痛的疗效和不良反应。方法84例中、重度癌痛患者随机分为奥施康定治疗组或芬太尼透皮贴组。奥施康定组初始剂量10mg/12h,正在用吗啡镇痛者,按照吗啡0.5荆量换算。芬太尼透皮贴组初始剂量为25μg/h,正在用吗啡镇痛者,按照芬太尼透皮贴(μg/h)=每日吗啡剂量(mg)×0.5换算。根据疼痛情况调整剂量,每位患者至少治疗两周,同时进行疼痛强度、生活质量评分及不良反应观察。结果奥施康定组41例疼痛缓解率为92.68%;多瑞吉组43例为93.02%。两组患者生活质量均明显提高,主要不良反应为便秘。结论奥施康定和多瑞吉治疗中、重度癌痛疗效均显著,不良反应较少,能显著改善癌症患者的生活质量。

关 键 词:奥施康定  芬太尼透皮贴剂  治疗  癌痛

The Clinical Study for the Effect of Oxycontin or Transdermal Fentanyl on Moderate and Severe Cancer Pain
QIN Xintian,LI Yuqi,WANG Xicheng,SHU Yangchun,LIU Kuifeng.The Clinical Study for the Effect of Oxycontin or Transdermal Fentanyl on Moderate and Severe Cancer Pain[J].Medicine Healthcare Apparatus,2011(2):229-231.
Authors:QIN Xintian  LI Yuqi  WANG Xicheng  SHU Yangchun  LIU Kuifeng
Institution:QIN Xintian,LI Yuqi,WANG Xicheng,SHU Yangchun,LIU Kuifeng(Department of Oncology,the First Affiliated Hospital of Guangdong Pharmaceutical University,Guangzhou 510080,China)
Abstract:Objective To observe the analgesic efficacy and adverse effects of oxycontin(oxycodone hydrechloride controlled-release tables) or transdermal fentanyl on moderate and severe chronic cancer pain by contrast.Methods 84 patients with moderate or severe chronic cancer pain were randomly divided into oxycontin group or fentanyl group.Oxycontin was administrated at an initial dose of 10 mg every 12 hours,the patients taking morphine switched to oxycontin with dose equal to half of morphine;The transdermal fentan...
Keywords:Oxycontin  Transdermal fentanyl  Therapy  Cancer pain  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号